Wells Fargo Maintains Equal-Weight on Exelixis, Raises Price Target to $40

Exelixis, Inc.

Exelixis, Inc.

EXEL

0.00

Wells Fargo analyst Eva Fortea Verdejo maintains Exelixis (NASDAQ: EXEL) with a Equal-Weight and raises the price target from $35 to $40.